ScienceDaily (Feb. 21, 2008) — People with a highly aggressive type of brain tumor who are missing a specific chromosome live longer and respond better to the chemotherapy drug temozolomide than people without this genetic abnormality, according to new research. Gliomatosis cerebri is a rare type of brain tumor that is difficult to diagnosis, cannot be operated on, and has an extremely variable prognosis.
